Mohammed Al-Sofiani

Associate Professor | Endocrinologist | interested in #Diabetes #Diabetes_Technology #Cardiometabolic Health | @_KSU @hopkinsmedicine |Tweets are my own opinion

[Mohammed Al-Sofiani @Moh_Endo]

The tweets in this account @Moh_Endo are in English only and mostly about #Endocrinology, #diabetes & #cardiometablic diseases #EndoTwitter

[Asra Ahmed @UpAsra]

· The “lived experience” representation, felt disappointingly isolated relegated to a few panels with limited integration into real policy. It’s hard to see how change will happen if those with lived experience are still speaking in silos. @dedocORG @diabesties1 @Moh_Endo

[Mohammed Al-Sofiani @Moh_Endo]

@AliceYYCheng Agree! It was a wonderful and highly educational symposium 👏🏼

[Mohammed Al-Sofiani @Moh_Endo]

Excited to attend the 85th ADA Scientific Sessions @ADA_DiabetesPro & present 9 research projects advancing diabetes care in Saudi Arabia🇸🇦 & the Middle East.

Grateful to our team, collaborators, policymakers, and the people living with diabetes who made this possible
#ADA2025

[Mohammed Al-Sofiani @Moh_Endo]

@EndoHopkins Congratulations to the best Chief Scientific and Medical Officer! Very well deserved👏🏼👏🏼👏🏼

[Reem Alshareef @reemjalshareef]

Enjoying attending and participating with my mentor Dr.Mohammed Alsofiani and my colleagues in the ATTD conference and looking forward to contribute more in research projects in the coming years!
@MalsofianiAR @Ali_Alnahari @Alfadl

#ATTDFaces #ATTD2025

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

Midway through Day 2 at #ATTD2025, and the energy is high! ⚡️

This morning, we explored the latest in CGM as a diagnostic tool, debated beta cell therapies, and explored cutting-edge tech at the exhibition.

Stay curious, and make the most of everything ATTD has to offer!

[Aliaa Alhashem @Dr_Aliaa11]

Led by our colleague @MalsofianiAR
This multi-center study concludes that users of AID systems
in Saudi Arabia 🇸🇦
>have the best glycemic control
>the least frequent hypoglycemia avoidance behaviors
compared to those using MDI, SAP, and SUP.
#ATTD2025

[Mohammed Al-Sofiani @Moh_Endo]

The 2024 World Diabetes Day Meeting at King Saud University. A very rich agenda 👌🏼

⏰ Saturday Nov 16

[Jazz Sethi @Jazzsethi95]

D-Coded latest article up now!!

We always try and D-code articles that people from the community can find useful and use in their lives!

Next one: Can People with #Type1Diabetes using AID technology fast safely during Ramadan ?

Head over to the Link:

https://t.co/pFnafeWsEY

[Mohammed Al-Sofiani @Moh_Endo]

📣We’re now accepting applications for our 2025-2027 Adult Endocrinology & Metabolism Fellowship Program @ksu_medicine

We offer 2 training tracks that are designed to deliver well-rounded clinical & research training to prepare you for the breadth & depth of clinical practice👇🏼

[Mohammed Al-Sofiani @Moh_Endo]

Proud of our Internal Medicine resident at King Saud University, Dr. Yara Alzamil 🇸🇦👏🏼👏🏼

She is doing an outstanding job presenting some of our latest data at the ADA 2024 meeting in Orlando 🇺🇸👏🏼👏🏼👏🏼

[Mohammed Al-Sofiani @Moh_Endo]

⏰ It’s time of the year…

Heading to #ADA2024 in Orlando 🇺🇸 to:
✅ Catch up with friends & colleagues
✅ Learn & exchange experiences
✅ Present & discuss some of our latest work from Saudi Arabia🇸🇦
✅ ….. and plan future global projects

See you there 🤝

[Division of Endocrinology @EndoHopkins]

Our pituitary center director Dr Salvatori in action at #ENDO2024!

[Mohammed Al-Sofiani @Moh_Endo]

@EndoHopkins @salmanzahoor 👏🏼👏🏼👏🏼👏🏼 Congratulations @salmanzahoor

[Division of Endocrinology @EndoHopkins]

❤️What a lovely time at the annual @EndoHopkins alumni dinner at #ENDO2024! Always a highlight at ENDO!

[Division of Endocrinology @EndoHopkins]

Super proud of our ⭐️fellow Dr Rabail Sadiq presenting her work on on the use of PSMA expression in cytologically indeterminate and malignant #thyroid nodules at #ENDO2024! Faculty mentor @endo_ps

[Advanced Technologies & Treatments for Diabetes @ATTDconf]

Ramadan Mubarak to all our Muslim followers!
For the occasion, we are sharing this insightful article with you: https://t.co/G9OhkDOjNi

The MiniMed 780G automated #insulin delivery system adapts to substantial changes in daily routine.

#ATTD24 #UNLOKEducation #Ramadan #Diabetes

[Mohammed Al-Sofiani @Moh_Endo]

@DiabetesCareADA @ADA_Pubs @DrEEverett1 @NesMathioudakis

[Mohammed Al-Sofiani @Moh_Endo]

🚨Our latest paper published in Diabetes Care.

❇️ Automated insulin delivery (AID) systems helped people with T1D:

1️⃣ Fast most days of Ramadan &
2️⃣ Maintain the best glycemic control during Ramadan

… compared to other modalities of T1D treatment

https://t.co/Ci0N71bazU

[Diabetes Care, an ADA research journal 🌟 @DiabetesCareADA]

Automated insulin delivery is the most effective and safe treatment modality for people with type 1 diabetes practicing intermittent fasting according to a multicenter prospective study from Saudi. @ADA_Pubs

Read Here➡️https://t.co/LnRwQG5WVp

[Mohammed Al-Sofiani @Moh_Endo]

Such a privilege to speak at the “Diabetes Innovation Summit for Central & Eastern Europe, Middle East, & Africa”, in Istanbul, Turkey about:

❇️The role of Automated Insulin Delivery(AID) during Ramadan fasting

👉🏼Next? Stay tuned for the clinical implications of all of this💡